GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                 
                                    Abbreviated name: TNFSF1
                                 
                            
                            
                               
                                                                Synonyms: LTα | TNFβ
                                 
                                                         
                            
                            
                            
                                Compound class: 
                                                            Endogenous peptide in human, mouse or rat
                                 
                                
                                    
                                        Comment: LTA (TNFβ) is a pro-inflammarory cytokine mediating a large variety of inflammatory, immunostimulatory, and antiviral responses. LTA is required during embryonic development of lymphoid organs.
                                    
                                 
                            
                                
                                    Species: Human
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
| References | 
| 
                                                                         1. Adams CW, Grogan JL, Gurney AL, McCutcheon K. (2011)
                                         Antibodies to lymphotoxin-alpha. Patent number: US7923011B2. Assignee: Genentech Inc. Priority date: 12/10/2006. Publication date: 12/04/2011.  |